Expertise in
3
conditions

Jose L. Manzano

Barcelona, CT, ES 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
3
conditions
Barcelona, CT, ES 

Overview

Jose Manzano practices practicing medicine in Barcelona, Spain.

Mr. Manzano is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Melanoma, Colorectal Cancer, Medullary Thyroid Carcinoma, and Neuroendocrine Tumor.

He is actively involved in clinical research, co-authoring 62 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Barcelona, CT, Spain
Other Locations
Badalona, CT, Spain
Complejo Hospitalario Universitario de A Coruña
A Coruna, GA, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
Enrollment Status: Recruiting
Publish Date: April 04, 2025
Intervention Type: Other
Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors
Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors
Enrollment Status: Active_not_recruiting
Publish Date: April 07, 2026
Intervention Type: Drug
Study Drug: Tisotumab Vedotin
Study Phase: Phase 2
Randomized Open Label Study to Compare the Efficacy and Safety of Everolimus Followed by Chemotherapy With Streptozotocin- Fluorouracilo (STZ-5FU) Upon Progression or the Reverse Sequence, in Advanced Progressive Pancreatic NETs (pNETs)
Randomized Open Label Study to Compare the Efficacy and Safety of Everolimus Followed by Chemotherapy With Streptozotocin- Fluorouracilo (STZ-5FU) Upon Progression or the Reverse Sequence, in Advanced Progressive Pancreatic NETs (pNETs)
Enrollment Status: Completed
Publish Date: May 11, 2025
Intervention Type: Drug
Study Drug: STZ-5FU
Study Phase: Phase 3
A Randomized Phase 3 Comparison of IMO-2125 With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)
A Randomized Phase 3 Comparison of IMO-2125 With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drugs: Ipilimumab, IMO-2125
Study Phase: Phase 3
View 3 Less Clinical Trials

62 Total Publications

Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision analysis.
Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision analysis.
Journal: Journal of pharmaceutical policy and practice
Published: December 19, 2025

Frequently Asked Questions about Jose L. Manzano

Is Jose L. Manzano a top-rated expert for Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Jose L. Manzano is classified as an Advanced expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jose L. Manzano participate in research or clinical trials?

Yes. Jose L. Manzano has published 62 articles and abstracts on conditions like Melanoma. You can view a list of Jose L. Manzano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Manzano's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile